Cagrilintide is a long‑acting acylated analogue of the pancreatic hormone amylin, designed for once‑weekly subcutaneous administration. It activates central amylin receptors to promote satiety, slow gastric emptying, and reduce food intake. In phase 2 and phase 3 trials, cagrilintide produced dose‑dependent weight loss with a predominantly gastrointestinal side‑effect profile.
Intended Use:
Cagrilintide is intended for research purposes only. All peptides require reconstitution with bacteriostatic water (BAC water), sold separately.
Storage:
Store in a cool, dry place away from light. After reconstitution, keep refrigerated at 2–8°C.
Solubility:
Best reconstituted with bacteriostatic water. Gently swirl—do not shake.
Vial Size:
Typically supplied in lyophilized powder form (multi-dose vial, compatible with up to 3ml BAC water).
Shelf Life:
Lyophilized: up to 24 months when properly stored
Reconstituted: recommended use within 4–6 weeks
Handling:
Use sterile techniques during reconstitution and handling to maintain stability and integrity.
Cagrilintide is a long-acting amylin analog designed for research in appetite regulation and metabolic control. It mimics the activity of natural amylin, a hormone co-secreted with insulin, and is commonly studied for its effects on satiety, gastric emptying, and energy balance.
Contact our online support for real-time communication about products, orders, shipping, payment, or bulk supply.
